ABOUT THIS YEAR
​> REGISTRATION
> AGENDA
​​> ATTENDEES
​> INVESTORS
​​> PRESENTERS
> RISING STARS
> NETWORKING
> SPONSORS
> SUPPORTERS
> VENUE
​> ACCOMMODATION
​
> ABOUT LAST YEAR

PARTICIPATING COMPANIES INCLUDE:

4BIO Capital
AbbVie Ventures
AbbVie, Inc.
Abingworth LLP
Accequa AB
Actelion, a Janssen Pharmaceuticals Company of Johnson & Johnson
ACXIT Capital Management GmbH
Adrenomed AG
Advent France Biotechnology
Advent Life Sciences
aescuvest international GmbH
Affibody AB
Affimed
Allecra Therapeutics GmbH
ALSA Holdings
Altitude Investment Management, LLC
Amryt Pharma Plc.
Anagenesis Biotechnologies
ANDERA Partners
Anima Biotech, Inc.
Anocca AB
Antagonis Biotherapeutics
Apollo Health Ventures
Arix Bioscience Plc.
Arrowfield Capital
ARTO AG
Arvelle Therapeutics
Ascenion GmbH
ATGN Consulting
Athira Pharma, Inc.
Avillion LLP
B.O. Consulting GmbH
Bachem AG
Banque Profil de Gestion SA
Bavarian Capital Management
Bay City Capital, LLC
BB Pureos Bioventures
BeiGene Ltd.
Bellevue Asset Management AG
Belsize Asset Management GmbH
BERNINA BioInvest Ltd
Bio Capital Impact Fund
Biognosys AG
BioM Biotech Cluster Development GmbH
BioMedPartners AG
BioNTech AG
BioPharma Advisory
BioSeed Capital
BioStart Consulting GmbH
Biotech Alliances International, Inc.
BiovelocITA S.r.l.
BioVersys AG
Bird & Bird LLP
Bloomberg L.P.
Boehringer Ingelheim International GmbH
Boehringer Ingelheim Venture Fund GmbH
BOHE Angel Fund
Bone Therapeutics SA
Boston Consulting Group
Breslin AG
Bridge Valley Venture LLP.
BROTHERS & PARTNERS EUROPE
Bryan, Garnier & Co
Cantargia AB
Capital Grand Est
Capricorn Venture Partners
Cardior Pharmaceuticals GmbH
Catalyze B.V.
CBC Group (C-Bridge Capital)
CDR-Life AG
Cederberg GmbH
Cellestia Biotech AG
Clarus Capital Group AG
Click Therapeutics, Inc.
CoFeS China Ltd.
Corbus Pharmaceuticals
Coulter Partners
Crescendo Biologics Ltd.
Cresset Group
Csendes Consulting
Cullgen, Inc.
Cyxone AB
Daiichi Sankyo, Inc.
DC Prime BV
DDF Ventures B.V.
Delin Ventures Ltd.
Deltec International Group
Dementia Discovery Fund
DHBW Lörrach
Digital Networks PLC
Dyadic International, Inc.
EA pharma Co., Ltd.
EIT Health e.V.
Eli Lilly and Company
EMD Serono
Emerging Technology Partners, LLC (ETP)
EpimAb Biotherapeutics GmbH
Ernst & Young AG
Esperante Ventures
European Investment Bank
F. Hoffmann-La Roche Ltd.
F2G Ltd.
Faron Pharmaceuticals Ltd.
FastVentures B.V.
Forbion
Fraser Finance LLP
Freeline Therapeutics
FreeMind Group
Gain Therapeutics
Galilee Cannabis Consortium
Genclis SA
Genenta Science
GeNeuro SA
GenSearch Switzerland GmbH
Gigabases Switzerland AG
Gilde Healthcare Partners
Gimv
GL Capital Group
Global Investment Bridge AG
GLSV GmbH
Goldman Sachs & Co.
Grabulovski Consulting Services GmbH, ex Co-Founder & CSO of Covagen
Gravitas Capital LLC
GrowthCube Partners LLC
Guggenheim Securities, LLC
H.C. Wainwright & Co., LLC
Hadean Ventures
HBM Partners AG
HealthCare Royalty Partners
High-Tech Gruenderfonds Management GmbH
Hoffmann & Co AG
HOOKIPA Pharma, Inc.
i&i Prague
ICF Consult (Switz.)
IGEM Therapeutics Ltd.
IKU
Illumina Ventures
Image Analysis Group
Imcyse SA
IMI Consulting GmbH
Immunicum AB
Indelve
Independent - HK
Independent - LC
Independent - RM
Industrifonden
Inkef Capital B.V.
Innogest Capital
Innovate Biopharmaceuticals, Inc.​

Inserm Transfert Initiative / Sofimac
Instinctif Partners Ltd.
International IB High School
Inveready Asset Management
Invest Securities
IO Biotech ApS
IPF Partners
Israeli Embassy in Bern, Switzerland
Italian Trade Agency (ITA)
JIH Vermögensverwaltungs GmbH
Jina Ventures, Inc.
Johnson & Johnson
Johnson & Johnson Innovation
Johnson & Johnson Innovation | Janssen Business Development
Justin Stindt Consulting GmbH
Juvenescence Ltd.
Kanton Basel-Stadt
Karyopharm Therapeutics, Inc.
Kempen & Co
KIZOO Technology Capital GmbH
KPMG
Kreos Capital Management (UK) Ltd.
Kuros Biosciences AG
Labatec Pharma SA
Life Science Animation
LifeCare Partners
LifeSci Advisors
Lilly Asia Ventures
Lipum AB
LMU Munich
Locust Walk
Lombard Odier
Lonza AG
LyGenesis, Inc.
M Ventures
MainFirst Bank AG
Marker Therapeutics, Inc. (formerly TapImmune Inc.)
Medicxi
MedinCell S.A.
medme
Memo Therapeutics AG
MercachemSyncom
Merck
Merck KGaA
MetrioPharm AG
Metys Pharmaceuticals AG
Mirabaud Securities Ltd.
Momentum Biotech
MSD
Mymetics SA
Nasdaq OMX
NBE-Therapeutics Ltd.
Neuraxpharm
Neurimmune AG
NeuroVive Pharmaceutical AB
Norgine Ventures
Novadip Biosciences
NovaGo Therapeutics AG
Novaremed AG
Novartis International AG
Novartis Oncology
Novo Holdings A/S
Novo Nordisk A/S
NxR Biotechnologies GmbH
O2H Ventures Ltd.
Omnix Medical Ltd.
OrbiMed Advisors LLC
Oryzon Genomics S.A.
Otsuka Pharmaceutical Europe Ltd.
OxStem Limited
Oxurion NV
Panakes Partners SBMT SpA
Parkinson’s UK
Partner International, Inc.
PDC*line Pharma SA
Perseo Pharma AG
Pfizer, Inc.
PharmaVentures Ltd.
Pharmstandard Ventures
Portugal Ventures SCR, SA
Premier Research
Primex Pharmaceuticals AG
Quan Capital
RBV Capital
Redalpine Venture Partners AG
Research Toxicology Centre (RTC)
RhoVac AB
Roivant Sciences GmbH
RSA Consulting Ltd.
Ruffena Capital Ltd.
Sachs Associates Ltd.
Salus Partners SA
Sanofi
Schroder Adveq
Schwarz Financial Communication
Senolytic Therapeutics, Inc.
Seroba Life Sciences
Seventure Partners SA
Silicon Valley Bank
SIX Swiss Exchange
Sofinnova Investments
Sofinnova Partners SA
Sosei Heptares
Staatz Business Development & Strategy
STALICLA S.A.
State of Israel to Switzerland and Liechtenstein
STERO Biotechs Ltd.
Stifel Financial Corp.
Sunstone Life Science Ventures A/S
SVB Leerink
Swedbank Robur AB
Swiss Biotech Association
Syncrosome
Syneos Health
Takeda Pharmaceuticals International AG
TargImmune Therapeutics AG
The Fulford Group Ltd.
The Janssen Pharmaceutical Companies of Johnson & Johnson
Themis Bioscience GmbH
TheraVenture GmbH
TiVenture
TOLREMO Therapeutics AG
Topadur Pharma AG
Torreya Partners (Europe) LLP
TruVenturo GmbH
Turos Capital AG
TVM Capital Life Science
University of Turin
University of Zurich
V-Bio Ventures
Valor Management S.A.
valuationLAB AG
Ventac Partners GmbH
Venture Valuation AG
Versameb AG
Versantis AG
Vesalius Biocapital Partners Sàrl
Vetter Pharma International GmbH & Co. KG
VI Partners AG
Viopas Partners
Virometix AG
Vogel BioC
Wellington Partners
Wille AG
Xeraya Capital
XOventure GmbH
Yafo Capital
Yorkville Advisors, LLC
Ysios Capital Partners
Zai Lab Ltd.

* More to be announced. Last updated on 01.08.2019